Criterios Médicos de elegibilidad para el uso de anticonceptivos de la OMS
| dc.contributor.author | Capella, Daniela | |
| dc.contributor.author | Schilling, Andrea | |
| dc.contributor.author | Villaroel., Claudio | |
| dc.date.accessioned | 2018-01-22T16:07:59Z | |
| dc.date.available | 2018-01-22T16:07:59Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | Introduction: The "Medical Eligibility Criteria for Contraceptive Use" published by the World Health Organization (WHO) is a guide for the correct choice and use of the contraceptive methods in many different health conditions. In this document we will review the main changes made in the fifth and last edition of this guide published in English in 2015. Development: The modifications of this last edition are the addition of new contraceptive methods and the modification of the category of the recommendation for some health conditions. It adds the medroxiprogesterone acetate subcutaneous injection, the progesterone vaginal ring, the subcutaneous contraceptive implant sinoimplant(II)® and ulipristal acetate as emergency contraception. There are modifications of the recommendations for breastfeeding women, allowing the use of some progestin only methods since the immediate postpartum, with the exception of medroxiprogesterone acetate because it delivers a high dose of the steroid and the levonorgestrel intrauterine device that follows the same recommendations as the copper intrauterine device. There are also modifications in the recommendations for the use of combined contraceptives in the first 42 days postpartum, with more restrictions for non-breastfeeding women. Finally, on the use of antiretroviral therapy drugs, there were changes of some categories and a detailed categorization for each drug. Conclusion: It is necessary for health care providers to know these changes in order to deliver a quality care to contraception users. | |
| dc.format.extent | 7 | |
| dc.identifier.citation | Rev Chil Obstet Ginecol 2017; 82(2) | |
| dc.identifier.uri | http://hdl.handle.net/11447/1940 | |
| dc.identifier.uri | http://dx.doi.org/10.4067/S0717-75262017000200012 | |
| dc.language.iso | spa | |
| dc.publisher | Sociedad Chilena de Obstetricia y Ginecología | |
| dc.subject | contraception | |
| dc.subject | breastfeeding | |
| dc.subject | medroxyprogesterone | |
| dc.subject | levonorgestrel | |
| dc.subject | ulipristal | |
| dc.title | Criterios Médicos de elegibilidad para el uso de anticonceptivos de la OMS | |
| dc.type | Artículo |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Criterios Médicos de elegibilidad para el uso de anticonceptivos de la OMS.pdf
- Size:
- 176.54 KB
- Format:
- Adobe Portable Document Format
- Description:
- Resumen